277 related articles for article (PubMed ID: 14748654)
1. Pentostatin (Nipent) in the treatment of chronic lymphocyte leukemia and hairy cell leukemia.
Dillman RO
Expert Rev Anticancer Ther; 2004 Feb; 4(1):27-36. PubMed ID: 14748654
[TBL] [Abstract][Full Text] [Related]
2. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
Kraut EH
Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
[TBL] [Abstract][Full Text] [Related]
3. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
4. Clinical overview of pentostatin (Nipent) use in lymphoid malignancies.
Dearden CE; Matutes E; Catovsky D
Semin Oncol; 2000 Apr; 27(2 Suppl 5):22-6. PubMed ID: 10877047
[TBL] [Abstract][Full Text] [Related]
5. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
Ho AD; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
[TBL] [Abstract][Full Text] [Related]
6. Pentostatin and purine analogs for indolent lymphoid malignancies.
Ho AD; Hensel M
Future Oncol; 2006 Apr; 2(2):169-83. PubMed ID: 16563086
[TBL] [Abstract][Full Text] [Related]
7. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.
O'Dwyer PJ; Cheson BD; Leyland-Jones B; King SA; Hoth DF
Oncology (Williston Park); 1988 Jun; 2(6):17-23, 26-7. PubMed ID: 3079330
[TBL] [Abstract][Full Text] [Related]
8. Pentostatin in the treatment of hairy-cell leukemia.
Grever MR; Doan CA; Kraut EH
Best Pract Res Clin Haematol; 2003 Mar; 16(1):91-9. PubMed ID: 12670468
[TBL] [Abstract][Full Text] [Related]
9. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
Ho AD; Thaler J; Willemze R; Lauria F; Derossi G; Kuse R; Stryckmans P; Blanc CM; Cataldo F; McVie G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
[TBL] [Abstract][Full Text] [Related]
10. A phase I and II study of pentostatin (Nipent) with cyclophosphamide for previously treated patients with chronic lymphocytic leukemia.
Weiss MA
Semin Oncol; 2000 Apr; 27(2 Suppl 5):41-3. PubMed ID: 10877051
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with 2'-deoxycoformycin.
Catovsky D
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S103-7. PubMed ID: 9137963
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
Johnston JB; Eisenhauer E; Wainman N; Corbett WE; Zaentz SD; Daeninck PJ
Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
[TBL] [Abstract][Full Text] [Related]
13. Pentostatin: impact on outcome in hairy cell leukemia.
Grever MR
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1099-108. PubMed ID: 16990110
[TBL] [Abstract][Full Text] [Related]
14. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
Spiers AS
Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
[TBL] [Abstract][Full Text] [Related]
15. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
16. Activity of pentostatin (Nipent) in cutaneous T-cell lymphoma: single-agent and combination studies.
Foss FM
Semin Oncol; 2000 Apr; 27(2 Suppl 5):58-63. PubMed ID: 10877054
[TBL] [Abstract][Full Text] [Related]
17. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
[No Abstract] [Full Text] [Related]
18. Pentostatin in chronic lymphocytic leukemia.
Sauter C; Lamanna N; Weiss MA
Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1217-22. PubMed ID: 18721115
[TBL] [Abstract][Full Text] [Related]
19. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D
Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328
[TBL] [Abstract][Full Text] [Related]
20. [Successful treatment of hairy cell leukemia prolymphocytic variant with 2'-deoxycoformycin].
Nagai T; Izumi T; Noborio K; Takatoku M; Ohtsuki T; Machii T; Komatsu N; Ozawa K
Rinsho Ketsueki; 2002 Jul; 43(7):583-5. PubMed ID: 12229130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
